Clinical Trial Update: Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating SHR-8068 plus adebrelimab and bevacizumab versus sintilimab plus bevacizumab for advanced hepatocellular carcinoma is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Bevacizumab (bevacizumab)
• SHR-8068
• Sintilimab (sintilimab)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced Hepatocellular Carcinoma | Phase 3 | Status: RECRUITING